Patent infringement: Lupin's arm to pay damages to Bayer

An Australian court has asked Generic Health to pay A$30 million to Bayer Pharmaceuticals

The Federal Court of Australia has ruled against pharma major Lupin’s Australian arm, Generic Health, in a patent infringement case with Bayer Pharmaceuticals.

In the order, the Australian court has asked Generic Health to pay an amount of A$30 million to Bayer Pharmaceuticals for causing loss of revenue. Bayer had sued Generic Health for infringement of its patent for a contraceptive called Yasmin.

Lupin did not respond to queries sent by Business Standard.

Bayer, which markets a contraceptive called Yasmin, had alleged that Generic Health violated the patent by marketing Isabelle. The court observed that for Bayer, every sale of Isabelle led to